Share Prices & Company Research

Stockbroking

Omega Diagnostics Group

Current Price 10.02p Bid 10.00p Ask 10.80p Change 0.00%
Last Updated: 13/11/2019 15:10. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Omega Diagnostics Group plc (formerly Quintessentially English plc) is a medical diagnostics company focused on allergy, food intolerance and infectious disease. Omega provide high quality in-vitro diagnostics products for use in hospitals, clinics, laboratories and healthcare practitioners in over 75 countries and specialise in the areas of allergy and autoimmune, food intolerance and infectious disease. These results reflect the actions taken last year as part of the Board's strategic review to divest the non-core infectious disease business and to close the German allergy business.

Financial Highlights Year Ended 31/03/2019

Turnover
£9.76m
Operating Profit
£1.28m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
13.00

Key Personnel

Colin King
Chief Executive Officer
Kieron Antony Harbinson
Finance Director
Jeremy Howard Millard
Non-Executive Director
William Edward Rhodes
Non-Executive Int Chairman
Jagjit Singh Grewal
Sales Director

Stock Details

EPIC
ODX
ISIN
GB00B1VCP282
Shares in Issue
150,307,010
Market cap
£15.63m

Analyst Views (1)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
100.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
10.40p
Bid Price
10.00p
Ask Price
10.80p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
0.00p
Previous Close
10.40p
Intraday High
0.00p
Intraday Low
0.00p
52 Week High
17.70p
52 Week Low
8.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Omega Diagnostics Group Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Tangible Assets
1.6
1.7
Intangible Assets & Goodwill
17.0
15.0
Investments & Other Non-Current Assets
1.4
1.3
Total Non-Current Assets
20.0
18.0
Inventory
1.0
1.8
Trade & Receivables
2.5
3.0
Cash & Receivables
0.0
0.1
Other Current Assets & Assets Held for Resale
0.0
0.0
Total Assets
23.5
22.9

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Short Term Liabilities
2.3
2.8
Long Term Liabilities
3.0
3.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
5.3
5.8

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Net Assets
18.2
17.1

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Share Capital
19.8
19.8
Minority Interests
0.0
0.0
Retained Earnings
-1.7
-2.7
Share Premium Account
0.0
0.0
Other Equity
0.1
0.0
Total Equity
18.2
17.1

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Cashflow from Operating Activities
0.4
-0.8
Cashflow Before Financing
-0.5
-4.1
Increase / Decrease in Cash
0.0
-0.6

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Turnover
9.8
13.6
Cost of Sales
3.6
5.4
Gross Profit
6.2
8.2
Operating Profit
1.3
-6.9
Pre-Tax Profit
1.2
-6.9
Profit / Loss for the Year
1.0
-7.3
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.